Association Between Bleeding Events and In-hospital Mortality After Percutaneous Coronary Intervention
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
IMPORTANCE: Bleeding is the most common complication after percutaneous coronary intervention (PCI) and is associated with increased morbidity and health care costs. The incidence of bleeding-related mortality after PCI has not been described in a nationally representative population. Furthermore, the relationships among bleeding risk, bleeding site, and mortality are unclear. OBJECTIVES: To describe the association between bleeding events and in-hospital mortality after PCI and to estimate the adjusted population attributable risk (estimated as the proportion of mortality risk associated with bleeding events), risk difference, and number needed to harm (NNH) for bleeding-related in-hospital mortality after PCI. DESIGN, SETTING, AND PATIENTS: Data from 3,386,688 procedures in the CathPCI Registry performed in the United States between 2004 and 2011 were analyzed. The population attributable risk was calculated after adjustment for baseline demographic, clinical, and procedural variables. To calculate the NNH for bleeding-related mortality, a propensity-matched analysis was performed. MAIN OUTCOME MEASURES: In-hospital mortality. RESULTS: There were 57,246 bleeding events (1.7%) and 22,165 in-hospital deaths (0.65%) in 3,386,688 PCI procedures. The adjusted population attributable risk for mortality related to major bleeding was 12.1% (95% CI, 11.4%-12.7%) in the entire CathPCI cohort. The propensity-matched population consisted of 56,078 procedures with a major bleeding event and 224 312 controls. In this matched cohort, major bleeding was associated with increased in-hospital mortality (5.26% vs 1.87%; risk difference, 3.39% [95% CI, 3.20%-3.59%]; NNH = 29 [95% CI, 28-31]; P < .001). The association between major bleeding and in-hospital mortality was observed in all strata of preprocedural bleeding risk (low: 1.62% vs 0.17%; risk difference, 1.45% [95% CI, 1.13%-1.77%], NNH = 69 [95% CI, 57-88], P < .001; intermediate: 3.27% vs 0.71%; risk difference, 2.56% [95% CI, 2.33%-2.79%], NNH = 39 [95% CI, 36-43], P < .001; and high: 8.16% vs 3.45%; risk difference, 4.71% [95% CI, 4.35%-5.07%], NNH = 21 [95% CI, 20-23], P < .001). Although both access-site and non-access-site bleeding were associated with increased in-hospital mortality (2.73% vs 1.87%; risk difference, 0.86% [95% CI, 0.66%-1.05%], NNH = 117 [95% CI, 95-151], P < .001; and 8.25% vs 1.87%; risk difference, 6.39% [95% CI, 6.04%-6.73%], NNH = 16 [95% CI, 15-17], P < .001, respectively), the NNH was lower for nonaccess bleeding. CONCLUSIONS AND RELEVANCE: In a large registry of patients undergoing PCI, postprocedural bleeding events were associated with increased risk of in-hospital mortality, with an estimated 12.1% of deaths related to bleeding complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Austin, P. C. (2009) · Statistics in Medicine · doi:10.1002/sim.3697 · Cited by 6,758 · cited 3×
“303 394 47 844 11 868 Non-ACS 37 (33-42) Age, y 1731 1431 145 499 36 239 <75 36 (34-39) 2462 1520 78 813 19 839 ≥75 22 (20-24)”
Austin, P. C. (2011) · Pharmaceutical Statistics · doi:10.1002/pst.433 · Cited by 3,949 · cited 4×
“303 394 47 844 11 868 Non-ACS 37 (33-42) Age, y 1731 1431 145 499 36 239 <75 36 (34-39) 2462 1520 78 813 19 839 ≥75 22 (20-24)”
InfluentialBivalirudin for Patients with Acute Coronary Syndromes
Stone, G. W., McLaurin, B. T., Cox, D. A., Bertrand, M. E., Lincoff, A. M., Moses, J. W., White, H. D., Pocock, S. J., Ware, J. H., Feit, F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062437 · Cited by 1,459
Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes
Eikelboom, J. W., Mehta, S. R., Anand, S. S., Xie, C., Fox, K. A. A., & Yusuf, S. (2006) · Circulation · doi:10.1161/circulationaha.106.612812 · Cited by 1,341
Jolly, S. S., Amlani, S., Hamon, M., Yusuf, S., & Mehta, S. R. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.08.023 · Cited by 1,074
Manoukian, S. V., Feit, F., Mehran, R., Voeltz, M. D., Ebrahimi, R., Hamon, M., Dangas, G. D., Lincoff, A. M., White, H. D., Moses, J. W., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.027 · Cited by 798
Impact of Bleeding Severity on Clinical Outcomes Among Patients With Acute Coronary Syndromes
Rao, S. V., O’Grady, K., Pieper, K. S., Granger, C. B., Newby, L. K., Van de Werf, F., Mahaffey, K. W., Califf, R. M., & Harrington, R. A. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.06.056 · Cited by 631
Self-citationKinnaird, T. D., Stabile, E., Mintz, G. S., Lee, C. W., Canos, D. A., Gevorkian, N., Pinnow, E. E., Kent, K. M., Pichard, A. D., Satler, L. F., et al. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00972-x · Cited by 542
Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions
Ndrepepa, G., Berger, P. B., Mehilli, J., Seyfarth, M., Neumann, F.-J., Schömig, A., & Kastrati, A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.040 · Cited by 471
Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention
Peterson, E. D., Dai, D., DeLong, E. R., Brennan, J. M., Singh, M., Rao, S. V., Shaw, R. E., Roe, M. T., Ho, K. K. L., Klein, L. W., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.02.005 · Cited by 457
Self-citationAustin, P. C. (2009) · Medical Decision Making · doi:10.1177/0272989x09341755 · Cited by 454
Brindis, R. G., Fitzgerald, S., Anderson, H. V., Shaw, R. E., Weintraub, W. S., & Williams, J. F. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01372-9 · Cited by 387
Mehran, R., Pocock, S. J., Stone, G. W., Clayton, T. C., Dangas, G. D., Feit, F., Manoukian, S. V., Nikolsky, E., Lansky, A. J., Kirtane, A., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp110 · Cited by 365
Marso, S. P. (2010) · JAMA · doi:10.1001/jama.2010.708 · Cited by 300
Self-citationStone, G. W., Bertrand, M. E., Moses, J. W., Ohman, E. M., Lincoff, A. M., Ware, J. H., Pocock, S. J., McLaurin, B. T., Cox, D. A., Jafar, M. Z., et al. (2007) · JAMA · doi:10.1001/jama.297.6.591 · Cited by 299
Self-citationMehta, S. K., Frutkin, A. D., Lindsey, J. B., House, J. A., Spertus, J. A., Rao, S. V., Ou, F.-S., Roe, M. T., Peterson, E. D., & Marso, S. P. (2009) · Circulation: Cardiovascular Interventions · doi:10.1161/circinterventions.108.846741 · Cited by 299
Self-citationSpiegelman, D., Hertzmark, E., & Wand, H. C. (2007) · Cancer Causes & Control · doi:10.1007/s10552-006-0090-y · Cited by 298 · cited 3×
“303 394 47 844 11 868 Non-ACS 37 (33-42) Age, y 1731 1431 145 499 36 239 <75 36 (34-39) 2462 1520 78 813 19 839 ≥75 22 (20-24)”
Verheugt, F. W. A., Steinhubl, S. R., Hamon, M., Darius, H., Steg, P. G., Valgimigli, M., Marso, S. P., Rao, S. V., Gershlick, A. H., Lincoff, A. M., et al. (2011) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2010.10.011 · Cited by 248
Self-citationAustin, P. C. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1673 · Cited by 238
Lópes, R. D., Alexander, K. P., Manoukian, S. V., Bertrand, M. E., Feit, F., White, H. D., Pollack, C. V., Hoekstra, J. W., Gersh, B. J., Stone, G. W., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.12.021 · Cited by 134
Pocock, S., Mehran, R., Clayton, T. C., Nikolsky, E., Parise, H., Fahy, M. P., Lansky, A. J., Bertrand, M. E., Lincoff, A. M., Moses, J. W., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.878017 · Cited by 128
Cohen, D. J., Lincoff, A. M., Lavelle, T. A., Chen, H.-L., Bakhai, A., Berezin, R. H., Jackman, J. D., Sarembock, I. J., & Topol, E. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.05.085 · Cited by 119
Self-citationLindsey, J. B., Marso, S. P., Pencina, M. J., Stolker, J. M., Kennedy, K. F., Rihal, C. S., Barsness, G. W., Piana, R. N., Goldberg, S. L., Cutlip, D. E., et al. (2009) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2009.09.002 · Cited by 85
Self-citationEstimating adjusted NNT measures in logistic regression analysis
Bender, R., Kuß, O., Hildebrandt, M., & Gehrmann, U. (2007) · Statistics in Medicine · doi:10.1002/sim.3061 · Cited by 67
Predictors of length of stay after coronary stenting
Aronow, H. D., Peyser, P. A., Eagle, K. A., Bates, E., Werns, S. W., Russman, P. L., Crum, M. A., Harris, K., & Moscucci, M. M. (2001) · American Heart Journal · doi:10.1067/mhj.2001.119371 · Cited by 54
Estimating adjusted NNTs in randomised controlled trials with binary outcomes: A simulation study
Bender, R., & Vervölgyi, V. (2010) · Contemporary Clinical Trials · doi:10.1016/j.cct.2010.07.005 · Cited by 17
Cited by
Valgimigli, M., Gagnor, A., Calabró, P., Frigoli, E., Leonardi, S., Zaro, T., Rubartelli, P., Briguori, C., Andò, G., Repetto, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60292-6 · Cited by 1,303
Self-citationTantry, U. S., Bonello, L., Aradi, D., Price, M. J., Jeong, Y.-H., Angiolillo, D. J., Stone, G. W., Curzen, N., Geisler, T., ten Berg, J., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.101 · Cited by 910
Self-citationFerrante, G., Rao, S. V., Jüni, P., Da Costa, B. R., Reimers, B., Condorelli, G., Anzuini, A., Jolly, S. S., Bertrand, O. F., Krucoff, M. W., et al. (2016) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2016.04.014 · Cited by 524
Self-citationBernat, I., Horak, D., Stasek, J., Mates, M., Pesek, J., Ostadal, P., Hrabos, V., Dusek, J., Koza, J., Sembera, Z., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.08.1651 · Cited by 345
Kumbhani, D. J., Cannon, C. P., Beavers, C. J., Bhatt, D. L., Cuker, A., Gluckman, T. J., Marine, J. E., Mehran, R., Messe, S. R., Patel, N. S., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.09.011 · Cited by 308
Metadata
- Authors
- Chhatriwalla, A. K., Amin, A. P., Kennedy, K. F., House, J. A., Cohen, D. J., Rao, S. V., Messenger, J. C., Marso, S. P., & National Cardiovascular Data Registry, F. T.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2013-03-13
- Volume
- 309
- Issue
- 10
- Pages
- 1022
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2124859603
- Cited by
- 290
- References
- 26
- FWCI
- 29.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.